Wave life sciences to present at jefferies virtual healthcare conference

Cambridge, mass., may 28, 2021 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that paul bolno, md, mba, president and chief executive officer, is scheduled to give a presentation at the jefferies virtual healthcare conference on wednesday, june 2, 2021 at 11:30 a.m. et. dr. bolno will provide a corporate update and discuss wave's pipeline programs, including the first in vivo data from the company's adar editing discovery program for alpha-1 antitrypsin deficiency (aatd).
WVE Ratings Summary
WVE Quant Ranking